Overview

The Clinical Carbetocin Myocardium Trial

Status:
Completed
Trial end date:
2019-01-28
Target enrollment:
Participant gender:
Summary
Randomized comparison of different cardiotoxicity of carbetocin and oxytocin.
Phase:
Phase 4
Details
Lead Sponsor:
Oslo University Hospital
Treatments:
Carbetocin
Oxytocin